Please login to the form below

Not currently logged in
Email:
Password:

Trianta

This page shows the latest Trianta news and features for those working in and with pharma, biotech and healthcare.

Medigene buys cancer vaccine start-up

Medigene buys cancer vaccine start-up

Acquires Trianta to boost immuno-oncology business. Medigene has boosted its position in immuno-oncology with a 9.9m ($13.5m) deal to buy fellow German group Trianta, which is developing ... The Trianta team will be merged into Medigene and its managing

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2014 Pharma deals during January 2014

    Acquisitions. Finally, there is the continuing roll out of acquisitions, not all of which are for the big headline dollars. An interesting biotech:biotech deal was the acquisition of Trianta by

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics